Abstract
The simultaneous appearance of both multiple sclerosis (MS) and central nervous system (CNS) tumors is relatively uncommon. Whether the co-existence of two diseases is due to chance alone or the result of a causal relationship is still a matter of debate. There is also controversy about the effect of long-term exposure of MS patients to immunomodulatory drugs on the incidence of cancer. This paper reports two cases of rare CNS tumors (i.e., medulloblastoma and gliomatosis cerebri) in adult MS patients. Our cases emphasize that when uncommon neurological features appear in patients with MS, brain magnetic resonance imaging (MRI) ought to be done and brain biopsy should be considered to exclude a concomitant CNS disorder. These procedures are essential for the differential diagnosis and early treatment.
Similar content being viewed by others
References
Sadovnick AD, Eisen K, Ebers GC, Paty DW (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology 41:1193–1196
Brønnum-Hansen H, Koch-Henriksen N, Stenager E (2004) Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain 127:844–850
Achiron A, Barak Y, Gail M, Mandel M, Pee D, Ayyagari R, Rotstein Z (2005) Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments. Breast Cancer Res Treat 89:265–270
Reagan TJ, Freiman IS (1973) Multiple cerebral gliomas in multiple sclerosis. J Neurol Neurosurg Psychiatry 36:523–528
Anderson M, Hughes B, Jefferson M, Smith WT, Waterhouse JA (1980) Gliomatous transformation and demyelinating diseases. Brain 103:603–622
Khan OA, Bauserman SC, Rothman MI, Aldrich EF, Panitch HS (1997) Concurrence of multiple sclerosis and brain tumor: clinical considerations. Neurology 48:1330–1333
Bosch G (1912) Ein Fall von primaren Melanosarkom des Zentralnervensystem bei multipler sklerose. Zeit Med 33:917–922
Green AJ, Bollen AW, Berger MS, Oksenberg JR, Hauser SL (2001) Multiple Sclerosis and oligodendroglioma. Mult Scler 7:269–273
Sega A, Horvat A, Popovic M (2006) Anaplastic oligodendroglioma and gliomatosis type 2 in interferon-β teated multiple sclerosis patients Report of two cases. Clin Neurol Neurosurg 108:256–265
Feigin PD (2005) On cancer incidence in multiple sclerosis and effects of immunomodulatory treatment. Breast Cancer Res Treat 2:197
Frost PF, Laperriere NJ, Wong CS, Milosevic MF, Simpson WJ, Pintilie M (1995) Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 32(4):951–957
Yong VW (2009) Prospects of repair in multiple sclerosis. J Neur Sci 277:S16–S18
Arnon R, Aharoni R (2007) Neurogenesis and neuroprotection in the CNS—fundamental elements in the effect of glatiramer acetate on treatment of autoimmune neurological disorders. Mol Neurobiol 36:245–253
Madray MM, Greene JF, Butler DF (2008) Glatiramer acetate-associated, CD30+, primary, cutaneous, anaplastic large-cell lymphoma. Arch Neurol 65(10):1378–1379
Fuller GN, Kros JM (2007) Gliomatosis cerebri. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC Press, Lyon, pp 50–52
Tailliber S, Chodkiewicz C, Laigle-Donadey F, Napolitano M, Cartalat-Carel S, Sanson M (2006) Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature. J Neurooncol 76:201–205
Lucchimetti CF, Gavrilova RH, Metz I, Parisi JE, Scheithauer BW et al (2008) Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 131:1759–1775
Acknowledgments
We would like to acknowledge the contribution of Luis Monteiro, PhD, Elsa Silva and Isabel Ribeiro, MD (neurologist and neurosurgeon in our center). Dr. Heike Nesbit provided medical writing support for preparation of the manuscript on behalf of Merck Serono.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
da Silva, A.A.D.M., dos Santos Cavaco, S.M.P., Taipa, R.J.F. et al. Medulloblastoma and gliomatosis cerebri: rare brain tumors in multiple sclerosis patients. Neurol Sci 32, 893–897 (2011). https://doi.org/10.1007/s10072-010-0468-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-010-0468-1